MAP2K3 and non-small cell lung carcinoma: Tung et al. [30] demonstrated that pemetrexed increases MSH2 mRNA and protein levels in a manner dependent on MKK3/6-p38MAPK signal activation in NSCLC cells (H520, H1703).